Anteris Technologies Ltd. (AVR)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
8. 45
+0.11
+1.3189%
$
319.69M Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
- Eps
$ 8.34
Previous Close 
Want to track AVR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy
Anteris Technologies Global (NASDAQ: AVR) CEO and founder Wayne Paterson discussed the company's DurAVR transcatheter aortic valve replacement (TAVR) program, recent clinical visibility, and the company's approach to market development during a conversation that touched on product design, tissue science, reimbursement, and longer-term interest in heart failure care pathways. Clinical interest and a "total disease management"
Defenseworld | 4 months ago
